Form 8-K - Current report:
SEC Accession No. 0000950170-25-036503
Filing Date
2025-03-10
Accepted
2025-03-10 17:03:50
Documents
11
Period of Report
2025-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K trvi-20250310.htm   iXBRL 8-K 59934
  Complete submission text file 0000950170-25-036503.txt   180735

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT trvi-20250310.xsd EX-101.SCH 28532
13 EXTRACTED XBRL INSTANCE DOCUMENT trvi-20250310_htm.xml XML 4711
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38886 | Film No.: 25724672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)